Matica Bio opens new Texas cell and gene therapy facility 06-May-2022 By Rachel Arthur CDMO Matica Bio has opened a new 45,000-square-foot facility dedicated to the production of viral vectors and cell-based products used in cell and gene therapies, vaccines, oncolytic therapies and other genetic medicines.
Fujifilm Diosynth invests $35m in gene therapy manufacture 03-Mar-2020 By Ben Hargreaves Fujifilm Diosynth will expand its existing site in Texas to support the late-phase and commercial manufacture of gene therapies.
